Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia.
Point mutations in the granulocyte colony-stimulating factor receptor (G-CSFR) gene have been linked to the development of secondary leukemia in patients with congenital neutropenia (CN). This report presents data on a now 18-year-old patient with CN who has received G-CSF treatment since 1989 and who developed acute myeloid leukemia (AML) in 1998. To evaluate whether there is an association between the occurrence of point mutations of the G-CSFR gene and development of secondary AML, DNA/messenger RNA of neutrophils and mononuclear cells from this patient were analyzed at different time points by polymerase chain reaction and subsequent cloning by DNA sequencing of representative numbers of individual clones. Findings suggest an increasing instability of the G-CSFR gene in time as judged by increasing numbers of mutations proposed to be one important step in the development of AML in this patient.
Tschan
C A
CA
Department of Paediatric Haematology and Oncology, Hannover Medical School Hannover, Germany.
Pilz
C
C
Zeidler
C
C
Welte
K
K
Germeshausen
M
M
D000208:Acute Disease; D000293:Adolescent; D016026:Bone Marrow Transplantation; D018389:Codon, Nonsense; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000209:etiology* / Q000235:genetics / Q000517:prevention & control; D009503:Neutropenia / Q000150:complications / Q000151:congenital / Q000235:genetics*; D017354:Point Mutation; D016188:Receptors, Granulocyte Colony-Stimulating Factor / Q000235:genetics*; D013997:Time Factors
D018389:Codon, Nonsense; D016188:Receptors, Granulocyte Colony-Stimulating Factor